Now, it's up to the European Commission to confirm those potential green lights in the coming weeks and months.
GlobalData on MSN21h
EMA’s CHMP recommends Sanofi’s Sarclisa approval for multiple myelomaThe European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of ...
GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback